Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 2
1980 1
1981 1
1982 1
1984 2
1986 6
1987 7
1988 6
1989 16
1990 5
1991 4
1992 8
1993 2
1994 12
1995 10
1996 6
1997 4
1998 9
1999 6
2000 3
2001 6
2002 4
2003 4
2005 4
2006 5
2007 5
2008 8
2009 3
2010 3
2011 3
2012 6
2013 3
2014 1
2015 1
2016 2
2017 2
2018 2
2019 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Immune-mediated oligodendrocyte injury.
Compston DA, Scolding NJ. Compston DA, et al. Ann N Y Acad Sci. 1991;633:196-204. doi: 10.1111/j.1749-6632.1991.tb15610.x. Ann N Y Acad Sci. 1991. PMID: 1789547 Review. No abstract available.
The pathogenesis of demyelinating disease.
Scolding NJ, Zajicek JP, Wood N, Compston DA. Scolding NJ, et al. Among authors: compston da. Prog Neurobiol. 1994 Jun;43(2):143-73. doi: 10.1016/0301-0082(94)90011-6. Prog Neurobiol. 1994. PMID: 7972853 Review. No abstract available.
The morbidity of multiple sclerosis.
Swingler RJ, Compston DA. Swingler RJ, et al. Among authors: compston da. Q J Med. 1992 Apr;83(300):325-37. Q J Med. 1992. PMID: 1631264
HLA-DRB1 and multiple sclerosis in Malta.
Dean G, Yeo TW, Goris A, Taylor CJ, Goodman RS, Elian M, Galea-Debono A, Aquilina A, Felice A, Vella M, Sawcer S, Compston DA. Dean G, et al. Among authors: compston da. Neurology. 2008 Jan 8;70(2):101-5. doi: 10.1212/01.wnl.0000284598.98525.d7. Epub 2007 Dec 5. Neurology. 2008. PMID: 18057318
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.
Coles AJ, Cohen JA, Fox EJ, Giovannoni G, Hartung HP, Havrdova E, Schippling S, Selmaj KW, Traboulsee A, Compston DAS, Margolin DH, Thangavelu K, Chirieac MC, Jody D, Xenopoulos P, Hogan RJ, Panzara MA, Arnold DL; CARE-MS II and CAMMS03409 Investigators. Coles AJ, et al. Among authors: compston das. Neurology. 2017 Sep 12;89(11):1117-1126. doi: 10.1212/WNL.0000000000004354. Epub 2017 Aug 23. Neurology. 2017. PMID: 28835403 Free PMC article.
170 results